Genome Protection
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(716) 218-7157Website
www.genomeprotection.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Genome Protection
Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The Company's technologies are based on deep insights in the intrinsic mechanisms leading to genomic instability, impairment of immunity ("immunosenescence"), and systemic inflammation ("inflammaging") in aging. Genome Protection develops drugs that counteract these mechanisms, including TLR5 agonists entolimod and GP532, that are projected to improve immune functions in the elderly. The Company is also applying its broad research and development capabilities to fuel a sustainable pipeline of innovative small-molecule and immunotherapeutic drug candidates that target intrinsic mechanisms underlying genomic instability in somatic tissues during aging and cancer progression and driven by the activity of endogenous retroelements ('retrobiome').Explore more
Genome Protection Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genome Protection your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Genome Protection launches new products
Check if Genome Protection has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Genome Protection recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Genome Protection, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genome Protection has new funding data
Check out if Genome Protection is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Genome Protection
Click to see if Genome Protection had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Genome Protection
Compare insights from companies similar to Genome Protection, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Genome Protection is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genome Protection is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genome Protection.
Genome Protection financials insights
Gather financial insights about Genome Protection, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Genome Protection Tech Stack
A closer look at the technologies used by Genome Protection
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genome Protection
Sign Up For FreeTo access detailed company insights
Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The Company's technologies are based on deep insights in the intrinsic mechanisms leading to genomic instability, impairment of immunity ("immunosenescence"), and systemic inflammatio... Read More
